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INTRODUCTION  
Drug delivery through the skin has been a promising 
concept for a long time because skin is easy to access, has 
a large surface area with vast exposure to the circulatory 
and lymphatic networks and the route is noninvasive. 
Transdermal gel preparations are intended for superficial 
skin application or to some mucosal surfaces for local 
action or skin penetration of medicament or for their 
soothing or protective action. The nonsteroidal anti-
inflammatory drugs (NSAID’s) are having excellent anti-
inflammatory and analgesic activity but NSAID’s 
produces GIT ulceration, liver and kidney trouble in case 
of oral admin istration. To avoid the adverse effect, 
alternate routes of administration have been tried by 
investigators.
1
 The aim of this study was to develop 
suitable transdermal gel formulations of celecoxib using 
various gelling agent with permeation enhancers in order 
to reduce adverse drug reaction associated with oral 
formulat ions.  
Celecoxib was the first synthesized non-steroidal anti-
inflammatory drug (NSAID) able to selectively inhibit 
COX-2 activity
2
 and exhibits anti‐inflammatory, analgesic 
and antipyretic activities. It is chemically designated as 4-
[5-(4-methylphenyl)-3- (t rifluoromethyl)-1H-pyrazo l-1-y l] 
benzenesulfonamide and is a diaryl substituted pyrazole. It  
has been used in the treatment of rheumatoid arthritis, 
osteoarthritis, acute pain familial adenomatous polyposis, 
and primary dismenorrhea. Long term oral administration 
of celecoxib causes serious side effects, such as 
gastrointestinal toxicity, gastric mucosal ulceration, 
hemorrhage and recently, cardiotoxic effects, that restrict 
its oral use and make it a good candidate for transdermal 
administration.
3
 These potential side effects may be 
overcome by the topical admin istration of the drug .This 
route of drug delivery has gained popularity becaus e it 
avoids first pass effects, gastrointestinal irritation, and 
metabolic degradation associated with oral admin istration.  
Skin permeation enhancers could be used to improve drug 
skin penetration.
4
  Also, celecoxib having molecu lar 
weight of 381.38 and melt ing point in the range of   157-
158
o
C can be considered ideal to permeate through the 
skin.  An attempt has been made to use three different 
polymers of different class viz. natural, semi-synthetic and 
synthetic and evaluate the effect of these on release 
kinetics of the drug. 
The reasons for incorporating the drug Celecoxib into 
transdermal (Gel) drug delivery system include, it is non-
irritating to the skin, it is extensively bound to plasma 
proteins (97%), has short biological half-life & low 
molecular wt., could provide localized action at particular 
site. Also topical gels are non occlusive, easy to 
wash/clean, non staining hence have advantages over other 
topical routes.  
MATERIALS: 
Celecoxib was a kind gift sample from Alembic chemical 
works, Baroda. Carbapol 934 P was procured from 
Research Labs. Sodium carboxy methyl cellulose and 
Sodium alg inate were  procured from Loba chemie 
Mumbai.  A ll other ingredients  used were of analytical 
grade. 
METHODS: 
Various gel formulations were prepared using carbopol P 
940, sodium alginate and sodium CMC as gelling agents. 
Required quantity of gelling agent was weighted and 
dispersed in a small quantity of distilled water to form a  
homogeneous dispersion. 1% of Celecoxib was dissolved 
in suitable solvent (propylene glycol or ethanol) and added 
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to the above solution. Other excipients were also added 
with continuous stirring. In carbopol gels, pH of the gel 
was brought to skin pH by Triethanolamine. During pH 
adjustment, the mixture was stirred gently with a spatula 
until homogeneous gel was formed. All the samples were 
allowed to equilibrate for at least 24 hours at room 
temperature prior to performing rheological 
measurements.
5-10
 Final weight of the gel was adjusted to 
50 g with distilled water. The gels were stored in wide 
mouthed bottles. Entrapped air bubbles were removed.  
The prepared celecoxib gels were inspected visually for 
their color. The pH was measured using a pH meter 
reading at room temperature.  Similarly gel formulations of 
celecoxib were prepared using carbopol P 940 sodium 
CMC and sodium alginate with DMSO. 
Table 1: Composition of Optimized formulae of celecoxib gels  
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F1 1.00 2 -- -- 10.00 1.65 04.00 --- 100.00    
F2 1.00  6.25   10.00   ---  10.00 0.2 100 
F3 1.00   3.00  10.00    10 15.00 0.2 100 
F4 1.00 2   10.00 1.65 04.00 2.00 100.00    
F5 1.00  6.25   10.00   2.00  10.00 0.2 100 
F6 1.00   3.00  10.00   2.00 10 15.00 0.2 100 
All the values mentioned in the table  are in % W/W 
EVALUATION OF CELECOXIB GEL  
The prepared gels were evaluated for physical appearance, 
spreadability, pH, Extrudability drug content, and in vitro 
release study. The physical appearance and homogeneity 
of the prepared gels were tested by visual observations.  
pH:  
The pH of the gel formulations was determined using a pH 
meter (Elico LI 120). The measurement was performed at  
1st, 15th and 30th day after preparation to detect any pH 
fluctuations with time.  
Extrudability: 
In the present study, the method adopted for evaluating gel 
formulat ion for ext rudability was based upon the quantity 
in percentage of gel extruded from aluminum collapsible 
tube on application of weight in grams required to extrude 
at least 0.5 cm ribbon of gel in 10 seconds. More quantity 
extruded better was extrudability. The measurement of 
extrudability of each formulation was in triplicate and the 
average values are presented.
11 
The extrudability was then 
calculated by using the following formula:  
Extrudability = Applied weight to extrude gel from tube 
(in gm) / Area (in cm2) 
Spreadability:  
Spreadability was measured using the spreadability 
apparatus. The apparatus consists of two slides in which  
one slide is firmly fixed in a wooden frame while the other 
slide can easily slide over the surface of the fixed one. An 
excess of gel was placed between the two slides of the 
apparatus. A weight of 1Kg was allowed to rest on the 
slide for 5 minutes so that a uniform film of gel was 
formed and the air between the slides was expelled. The 
excess gel was removed carefully from the edges of the 
slides. The bottom slide was properly anchored and the top 
slide was subjected to a pull of 80 gms weight. The time  
(in seconds) required by the top slide to cover a distance of 
7.5 cm be noted. A shorter interval indicates better 
Spreadability.
12-16
 
Spreadability was then calculated using the following 
formula:  
S = M × L/ T  
Where, S = is the spreadability, M = is the weight in the 
pan (tied to the upper slide), L = is the length moved by 
the glass slide and T = represents the time taken to separate 
the slide completely  
In vi tro drug release: 
The in vitro drug release from gel formulations was 
studied across cellophane membranes using modified  
Keshery Chien diffusion cell
17
. The receptor compartment 
was filled with the mixture of  phosphate buffer of pH 5.6 
and polyethylene glycol 400 adjusted to pH 7.4 and 
maintained at 37 ± 0.5
o
C C with constant magnetic 
stirring. Accurately weighed quantity of gel was placed on 
the donor compartment. The samples (1ml) was collected 
from the receptor compartment at predetermined time 
interval and replaced by equal volume of fresh receptor 
solution to maintain constant volume allowing sink 
condition throughout the experiment. The amounts of 
celecoxib in the sample were assayed spectrometrically  
(Systronics 119 UV-Vis spectrophotometer) at 252 nm 
against appropriate blank. 
RES ULTS AND DISCUSS ION  
Physical examination 
The prepared Celecoxib gel fo rmulat ions were transparent 
in carbopol 934, white viscous in Na-CMC and brownish 
gummy in sodium alg inate with a smooth and 
homogeneous appearance. This might be due to the nature 
of gelling agent, carbapol being synthetic might be of most 
pure quality giving a clear appearance, while sodium CMC 
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being of semisynthetic category is resembling white 
viscous behavior. Sodium alginate was used as a natural 
gelling agent but due to the nature of alginic acid the 
formulat ion appeared brownish and gummy. They were 
also less viscous as compared to the other two. All the 
formulat ions were easily spreadable (Table 2). The pH 
values of all the prepared formulations ranged from 6.5 to 
7.0, which were considered acceptable to avoid the risk of 
irritation upon application to the skin.
18, 19
 
Table 2:  Physicochemical properties of celecoxib gels 
Formulation pH 
Spreadability 
Gm-cm/sec 
Extrudability 
Mean % drug release after  
12 hrs ± SD 
F1 6.70 ± 0.03 11.69 15.17 71.66±0.4674 
F2 7.09 ± 0.04 14.39 17.19 81.61±0.5609 
F3 6.56 ± 0.03 13.14 14.13 72.33±0.4795 
F4 6.35 ± 0.04 11.71 15.19 79.58±0.7158 
F5 6.39 ± 0.01 14.41 17.28 89.55±0.3308 
F6 6.54 ± 0.02 13.15 14.33 75.43±0.5774 
 
In-vi tro Diffusion Studies 
Diffusion studies were performed using Keshary-Chien 
diffusion cell apparatus. Accurately weighed quantity of 
sample was placed over the cellophane membrane which  
was placed over the donor compartment. A liquots of 
sample were withdrawn at specific intervals & drug release 
was determined. At the end of 12 hours the mean % drug 
release from 2% carbapol gel was found to be 73 %, from 
7.5 % Sodium alginate gel was found to be 82% & from 3 
% Na-CMC gel was found to be 72.3 %. 
The release studies clearly reveal that the drug celecoxib is 
released to a lesser extent from both synthetic and 
semisynthetic polymers. These polymers might be 
retarding the release of the drug while the drug is released 
to a greater extent in sodium alg inate as it is natural in 
nature. 
Table 3: In-Vitro Comparat ive Drug Release Profile of Formulation  F1, F2, F3, F4, F5 and F6 in %  
Time in 
hours 
F1 F2 F3 F4 F5 F6 
0 0 0 0 0 0 0 
1 08.81 08.86 08.00 08.26 08.21 08.18 
2 16.50 17.71 16.55 21.18 19.70 14.61 
3 19.94 20.72 21.53 27.40 27.34 23.91 
4 40.87 41.96 40.49 40.79 44.37 41.41 
5 45.85 52.93 43.37 52.41 65.38 51.17 
6 54.92 79.95 55.01 71.49 83.89 57.72 
12 71.66 81.61 72.33 79.58 89.56 75.43 
 
 
Figure 1: Comparative In-Vitro Release profile fro m 
Formulat ion F1, F2, F3 (without DMSO) 
Effect of penetration enhancer  
One of the approaches  for improving the topical drug 
delivery is use of penetration enhancer. In this study use of 
Dimethyl sulphoxide as penetration enhancer on the 
permeat ion of celecoxib has been studied.  Diffusion 
characteristics as 2% carbapol gel was found to be 80 %, 
from 7.5 % Sodium alg inate gel was found to be 90% & 
from 3 % Na-CMC gel was found to be 75.43 %. A net 
raise in penetration was observed to an extent of about 9%.  
 
Figure 2: Comparative In-Vitro Release profile from 
Formulat ion F4, F5, F6 (with DMSO) 
Karade et al                                  Journal of Drug Delivery & Therapeutics; 2012, 2(3): 132-135    135 
© 2011, JDDT. All Rights Reserved                                                 ISSN: 2250-1177                                               CODEN: JDDTAO  
CONCLUS ION: 
From above results, it can be concluded that celecoxib gel 
formulat ions were prepared with different gelling agents: 
carbopol, Na CMC and sodium alg inate showed acceptable 
physical properties and drug release study. All prepared 
gel showed acceptable physical properties concerning 
color, homogeneity, consistency, spreadability and pH 
value. Among all gel formulat ions, sodium alginate gel 
shows superior drug release followed by Na CMC, and 
Carbapol 940P showed decreasing order of drug release. In  
carbopol gel formulat ions, the drug release was decreased 
with increase in carbopol concentration because polymer 
concentration increases, viscosity increases. All gel 
formulat ions containing penetration enhancer (DMSO) 
were used. From  the  above  results  it  can  be  concluded  
that  the  celecoxib  gel  formulat ion  F5  containing  
6.25%  sodium alginate  with  2%  DMSO  was  suitable 
for topical application. 
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